BAMV - ETF AI Analysis

Top Page

Brookstone Value Stock ETF (BAMV)

Rating:72Outperform

Price Target:―

BAMV, the Brookstone Value Stock ETF, earns a solid overall rating thanks to several high-quality blue-chip holdings like Merck and Johnson & Johnson, which bring strong financial performance, healthy growth prospects, and supportive earnings trends. Defense and industrial names such as General Dynamics and Lockheed Martin, along with consumer staple PepsiCo, further strengthen the fund with steady cash flows and robust backlogs. The main risk is that some holdings face higher debt, valuation concerns, or weaker revenue and cash flow trends, and the fund has notable exposure to specific sectors like healthcare, defense, and energy, which could increase volatility if those areas come under pressure.

Positive Factors

Solid Recent Performance

The ETF has shown positive returns over the past month, three months, and year-to-date, indicating steady recent momentum.

Strong Top Holdings Mix

Several of the largest positions, including major technology, health care, energy, and defense companies, have delivered strong gains so far this year, supporting the fund’s overall results.

Broad Sector Diversification

Holdings are spread across multiple sectors such as technology, health care, industrials, financials, and consumer stocks, which helps reduce the impact if any one industry struggles.

Negative Factors

High Expense Ratio

The fund’s expense ratio is relatively high for an ETF, which means more of the returns are eaten up by fees over time.

Heavy U.S. Concentration

With nearly all assets invested in U.S. companies, the ETF offers little geographic diversification and is highly tied to the U.S. market’s fortunes.

Single-Stock and Sector Sensitivity

A meaningful share of assets is concentrated in a handful of large holdings and in technology and health care, so weakness in these stocks or sectors could weigh noticeably on performance.

BAMV vs. SPDR S&P 500 ETF (SPY)

AUM95.90M

RegionNorth America

Expense Ratio0.91%

Beta0.70

IssuerBrookstone

Inception DateSep 27, 2023

Dividend Yield1.27%

Asset ClassEquity

Index TrackedNo Underlying Index

Share Statistics

EPS (TTM)N/A

Shares OutstandingN/A

10 Day Avg. Volume14,180

30 Day Avg. Volume12,714

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

37.60

Price Target Upside― Downside

Rating ConsensusModerate Buy

Number of Analyst Covering30

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

BAMV Summary

The Brookstone Value Stock ETF (BAMV) is an actively managed fund that looks for U.S. companies the managers believe are undervalued but have solid business strength. It follows a value-investing theme across the total stock market, spreading money over many sectors like technology, health care, and industrials. Well-known holdings include Advanced Micro Devices (AMD), Johnson & Johnson, and Exxon Mobil. Someone might invest in BAMV to seek long-term growth while staying diversified across many types of companies. A key risk is that value stocks can stay out of favor for long periods, so the share price can go up and down with the market.

How much will it cost me?The Brookstone Value Stock ETF (BAMV) has an expense ratio of 0.91%, meaning you’ll pay $9.10 per year for every $1,000 invested. This is higher than average because it is actively managed, which typically involves more research and decision-making compared to passively managed funds that track an index.

What would affect this ETF?The Brookstone Value Stock ETF (BAMV) could benefit from positive trends in the technology and healthcare sectors, which make up a significant portion of its holdings, as well as potential growth in undervalued stocks during economic recoveries. However, rising interest rates or economic slowdowns could negatively impact its financial and industrial sector exposure, while regulatory changes in North America might affect its top holdings like AMD and Johnson & Johnson. Diversification across sectors helps mitigate some risks, but sector-specific challenges remain a key factor to watch.

BAMV Top 10 Holdings

BAMV’s story is driven by a mix of steady value stalwarts and one high-profile troublemaker. Health care heavyweights like Merck, Johnson & Johnson, and Bristol-Myers are quietly doing the heavy lifting, with rising share prices and solid fundamentals giving the fund a dependable backbone. Texas Instruments adds a tech tilt that’s been working in investors’ favor, while Exxon and Chevron keep the energy sleeve humming. The main drag is AMD, where recent weakness has taken some shine off returns. Overall, it’s a U.S.-focused, value-leaning portfolio with selective tech spice.

Name	Company Name	Weight %	Market Value	Market Cap	Yearly Gain	Overall Rating
LMT	Lockheed Martin	5.10%	$4.82M	$150.20B	39.51%	70 Outperform
JNJ	Johnson & Johnson	4.75%	$4.48M	$583.29B	48.50%	78 Outperform
MRK	Merck & Company	4.57%	$4.32M	$286.57B	22.38%	80 Outperform
XOM	Exxon Mobil	4.55%	$4.30M	$639.72B	41.28%	74 Outperform
BMY	Bristol-Myers Squibb	4.38%	$4.13M	$120.05B	-2.21%	78 Outperform
CVX	Chevron	4.24%	$4.00M	$393.03B	28.23%	71 Outperform
GD	General Dynamics	3.79%	$3.58M	$96.05B	36.02%	80 Outperform
PEP	PepsiCo	3.75%	$3.54M	$217.11B	7.09%	78 Outperform
DELL	Dell Technologies	3.73%	$3.52M	$99.34B	62.15%	65 Neutral
AMD	Advanced Micro Devices	3.73%	$3.52M	$322.40B	101.55%	73 Outperform

BAMV Technical Analysis

Technical Analysis Sentiment

Negative

Last Price―

Price Trends

50DMA

33.20

Negative

100DMA

32.67

Negative

200DMA

32.13

Positive

Market Momentum

MACD

-0.15

Positive

RSI

33.05

Neutral

STOCH

10.67

Positive

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For BAMV, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 33.17, equal to the 50-day MA of 33.20, and equal to the 200-day MA of 32.13, indicating a neutral trend. The MACD of -0.15 indicates Positive momentum. The RSI at 33.05 is Neutral, neither overbought nor oversold. The STOCH value of 10.67 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for BAMV.

BAMV Peer Comparison

Comparison Results

Name	Price	Price Target	AUM	Expense Ratio	Overall Rating
BAMV	―	―	$95.90M	0.91%	72 Outperform
TCV	―	―	$86.06M	0.85%	63 Neutral
GMOV	―	―	$79.16M	0.50%	73 Outperform
VUSV	―	―	$55.60M	0.30%	67 Neutral
GVLE	―	―	$42.25M	0.45%	72 Outperform
CVAR	―	―	$38.98M	0.87%	57 Neutral

Performance Comparison

BAMV

Brookstone Value Stock ETF

32.24

2.01

6.65%

TCV

Towle Value ETF

―

GMOV

GMO US Value ETF

―

VUSV

Vanguard Wellington U.S. Value Active ETF

―

GVLE

Goldman Sachs Value Opportunities ETF

―

CVAR

Cultivar ETF

―

Glossary

BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―

Table of Contents